Eisai seeks simultaneous approval for anticancer agent in Japan, US and Europe

Japanese pharmaceutical major Eisai Co. Ltd. has submitted applications to regulatory authorities in Japan, United State...

July 31, 2015 | Friday | News
Astellas, ClearPath to enter strategic partnership

Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio ...

January 6, 2014 | Monday | News
Eisai publishes phase III results of anti-seizure drug

Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized p...

July 26, 2012 | Thursday | News
FDA approves Eisai's gastro reflux drug

Singapore: US FDA approved Eisai's Aciphex Sprinkle delayed-release capsules 5mg and 10mg for the treatment of gastroeso...

March 27, 2013 | Wednesday | Regulatory
Asia an emerging hotspot in medical tourism

Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism.  Medical tour...

March 9, 2015 | Monday | Analysis
GSK receives marketing authorization for Nucala in Japan

Singapore: GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has grant...

March 30, 2016 | Wednesday | News
Taiho licenses oral anticancer drug to France's Servier

Japan's Taiho Pharmaceutical Co. Ltd. and France's Servier have entered into an exclusive license agreement on June 12, ...

June 16, 2015 | Tuesday | News
Daiichi, UCB seek marketing authorization for epilepsy drug in Japan

Japanese pharmaceutical firms, Daiichi Sankyo Company Limited and UCB Japan Co. Ltd have announced that UCB Japan has ap...

June 26, 2015 | Friday | News
PeptiDream, Teijin to co-discover peptide-based therapeutics

Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization co...

September 30, 2015 | Wednesday | News
Japan's Denka group to acquire German biopharma business

Singapore: Japan's Denki Kagaku Kogyo Kabushiki Kaisha (Denka Group) recently inked a pact to acquire Germany's Icon Gen...

August 12, 2015 | Wednesday | News
Ono, Bristol-Myers launch Orencia Auto-injector for treatment of Rheumatoid Arthritis

Osaka-headquartered Ono Pharmaceutical Co Ltd and Bristol-Myers Squibb K K have launched Orencia Subcutaneous Injection ...

May 25, 2016 | Wednesday | News
WuXi's subsidiary gets manufacturing nod in Japan

Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmace...

August 28, 2015 | Friday | News
Mednet, Biovisiq deal helps in zero-delay of trials

Singapore: AG Mednet signed a master services agreement with Biovisiq, a Japanese imaging core laboratory (ICL), to redu...

April 3, 2013 | Wednesday | News
Singulex's cardiovascular biomarker granted Japanese patent

Singulex Inc., California-based developer and provider of Single Molecule Counting technology for clinical diagnostics a...

April 29, 2015 | Wednesday | News
Chugai Pharma to set up sales unit in China

Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned dr...

December 26, 2013 | Thursday | News
Astellas, FibroGen start CKD anemia trial in Japan

Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...

July 31, 2013 | Wednesday | News
Cancer-specific killer T cells created from iPS cells

Singapore: Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan have succeeded, for the first ...

January 7, 2013 | Monday | News
Will Japan be able to reduce its generic drug prices?

The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...

May 21, 2013 | Tuesday | Analysis